SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-040653
Filing Date
2024-05-08
Accepted
2024-05-08 08:43:48
Documents
5
Period of Report
2024-05-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0204900-6k_inflarxnv.htm 6-K 15042
2 INFLARX N.V. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR ea020490001ex99-1_inflarxnv.htm EX-99.1 218455
3 INFLARX N.V. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES ea020490001ex99-2_inflarxnv.htm EX-99.2 159592
4 INFLARX N.V. PRESS RELEASE DATED MAY 8, 2024 ea020490001ex99-3_inflarxnv.htm EX-99.3 132007
5 GRAPHIC ex99-3_001.jpg GRAPHIC 2943
  Complete submission text file 0001213900-24-040653.txt   530375
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 24924414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)